Bristol-Myers Squibb Co
XHAM:BRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bristol-Myers Squibb Co
XHAM:BRM
|
US |
|
Aurora Cannabis Inc
TSX:ACB
|
CA |
|
EMX Royalty Corp
XTSX:EMX
|
CA |
|
Entech SA
PAR:ALESE
|
FR |
|
C
|
Cab Payments Holdings PLC
LSE:CABP
|
UK |
|
National Grid PLC
LSE:NG
|
UK |
|
JSR Corp
TSE:4185
|
JP |
|
E
|
eXeBlock Technology Corp
CNSX:XBLK.X
|
CA |
|
Star Entertainment Group Ltd
ASX:SGR
|
AU |
|
K
|
Krynica Vitamin SA
WSE:KVT
|
PL |
|
Toughbuilt Industries Inc
NASDAQ:TBLT
|
US |
|
SRT Marine Systems PLC
LSE:SRT
|
UK |
|
Terex Corp
NYSE:TEX
|
US |
|
R
|
Roche Holding AG
DUS:RHO
|
CH |
|
Cellnex Telecom SA
OTC:CLLNY
|
ES |
|
Worldline SA
OTC:WWLNF
|
FR |
|
Elemental Royalties Corp
XTSX:ELE
|
CA |
|
eGain Corp
NASDAQ:EGAN
|
US |
|
V
|
VICI Properties Inc
XMUN:1KN
|
US |
|
Avenue Supermarts Ltd
NSE:DMART
|
IN |
|
C
|
Canadian Imperial Bank of Commerce
XMUN:CAI
|
CA |
|
Dun & Bradstreet Holdings Inc
NYSE:DNB
|
US |
|
N
|
Novus Holdings Ltd
JSE:NVS
|
ZA |
|
B
|
BNP Paribas SA
DUS:BNP
|
FR |
Bankruptcy Probability
Bristol-Myers Squibb Co's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Bristol-Myers Squibb Co Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
560.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
401.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
298.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
221B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
47.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Bristol-Myers Squibb Co's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Bristol-Myers Squibb Co has total debt of 42.5B USD. This includes both short-term (319m USD) and long-term (42.2B USD) debt.
You can find a full breakdown on its Balance Sheet.
